Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.
INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Mylight150 create of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Lhyfe is a producer and supplier of green hydrogen, generated through renewable energy sources.
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Qovoltis offers smart charging solutions for electric vehicles and a mobile app for remote management.
Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Qualisteo, a start-up company based in Nice specialised in smart grids company.
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Andera Partners has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Andera Partners's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Medical Device. The firm invests across 27 different industry categories.
Among tracked funding rounds, Tubulis received $400.6M in a Series C round. Andera Partners's total known invested capital is $3.9B.
Andera Partners's average investment size is $81.0M across its portfolio of 63 companies.
Recent Andera Partners portfolio additions include Tricares, Exciva, INNOVO by Atlantic Therapeutics, Inotrem, mylight150. These companies were founded in 2020 or later.